Olaparib and bevacizumab in frontline maintenance of ovarian cancer: an over reliance in unpowered subgroup analysis of the PAOLA-1 trial?
- Author:
Eduardo PAULINO
1
;
Andreia Cristina de MELO
Author Information
- Publication Type:Correspondence
- From:Journal of Gynecologic Oncology 2020;31(6):e95-
- CountryRepublic of Korea
- Language:English
